Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The influence of developmental timing on B cell diversity.

Kristiansen TA, Vanhee S, Yuan J.

Curr Opin Immunol. 2018 Apr;51:7-13. doi: 10.1016/j.coi.2017.12.005. Epub 2017 Dec 19. Review.

2.

PTIP chromatin regulator controls development and activation of B cell subsets to license humoral immunity in mice.

Su D, Vanhee S, Soria R, Gyllenbäck EJ, Starnes LM, Højfeldt MK, Pedersen GK, Yuan J, Daniel JA.

Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9328-E9337. doi: 10.1073/pnas.1707938114. Epub 2017 Oct 16.

3.

Fetal to Adult Hematopoiesis with the "Flk" of a Switch.

Vanhee S, Yuan J.

Cell Stem Cell. 2016 Dec 1;19(6):673-674. doi: 10.1016/j.stem.2016.11.013.

4.

Pluripotent stem cell based gene therapy for hematological diseases.

Vanhee S, Vandekerckhove B.

Crit Rev Oncol Hematol. 2016 Jan;97:238-46. doi: 10.1016/j.critrevonc.2015.08.022. Epub 2015 Sep 14. Review.

PMID:
26381313
5.

Humanized Mice to Study Human T Cell Development.

Bonte S, Snauwaert S, Vanhee S, Dolens AC, Taghon T, Vandekerckhove B, Kerre T.

Methods Mol Biol. 2016;1323:253-72. doi: 10.1007/978-1-4939-2809-5_21.

PMID:
26294414
6.

In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis.

Vanhee S, De Mulder K, Van Caeneghem Y, Verstichel G, Van Roy N, Menten B, Velghe I, Philippé J, De Bleser D, Lambrecht BN, Taghon T, Leclercq G, Kerre T, Vandekerckhove B.

Haematologica. 2015 Feb;100(2):157-66. doi: 10.3324/haematol.2014.112144. Epub 2014 Nov 7.

7.

In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection.

Snauwaert S, Verstichel G, Bonte S, Goetgeluk G, Vanhee S, Van Caeneghem Y, De Mulder K, Heirman C, Stauss H, Heemskerk MH, Taghon T, Leclercq G, Plum J, Langerak AW, Thielemans K, Kerre T, Vandekerckhove B.

Leukemia. 2014 Apr;28(4):830-41. doi: 10.1038/leu.2013.285. Epub 2013 Oct 4.

PMID:
24091848
8.

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.

Snauwaert S, Vanhee S, Goetgeluk G, Verstichel G, Van Caeneghem Y, Velghe I, Philippé J, Berneman ZN, Plum J, Taghon T, Leclercq G, Thielemans K, Kerre T, Vandekerckhove B.

Haematologica. 2012 Oct;97(10):1539-47. doi: 10.3324/haematol.2012.065581. Epub 2012 Apr 24.

9.

Notch induces human T-cell receptor γδ+ thymocytes to differentiate along a parallel, highly proliferative and bipotent CD4 CD8 double-positive pathway.

Van Coppernolle S, Vanhee S, Verstichel G, Snauwaert S, van der Spek A, Velghe I, Sinnesael M, Heemskerk MH, Taghon T, Leclercq G, Plum J, Langerak AW, Kerre T, Vandekerckhove B.

Leukemia. 2012 Jan;26(1):127-38. doi: 10.1038/leu.2011.324. Epub 2011 Nov 4.

PMID:
22051534
10.

In vitro generation of immune cells from pluripotent stem cells.

Vandekerckhove B, Vanhee S, Van Coppernolle S, Snauwaert S, Velghe I, Taghon T, Leclercq G, Kerre T, Plum J.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1488-504. Review.

PMID:
21196243

Supplemental Content

Loading ...
Support Center